William Blair Reaffirms Outperform Rating for VistaGen Therapeutics (NASDAQ:VTGN)
VistaGen Therapeutics (NASDAQ:VTGN – Get Free Report)‘s stock had its “outperform” rating reiterated by equities researchers at William Blair in a note issued to investors on Wednesday,RTT News reports. William Blair also issued estimates for VistaGen Therapeutics’ Q1 2027 earnings at ($0.37) EPS, Q2 2027 earnings at ($0.43) EPS, Q3 2027 earnings at ($0.48) EPS […]
VistaGen Therapeutics (NASDAQ:VTGN – Get Free Report)‘s stock had its “outperform” rating reiterated by equities researchers at William Blair in a note issued to investors on Wednesday,RTT News reports. William Blair also issued estimates for VistaGen Therapeutics’ Q1 2027 earnings at ($0.37) EPS, Q2 2027 earnings at ($0.43) EPS, Q3 2027 earnings at ($0.48) EPS […]
